InvestorsHub Logo
Followers 5
Posts 563
Boards Moderated 0
Alias Born 08/19/2020

Re: None

Thursday, 10/21/2021 11:08:43 AM

Thursday, October 21, 2021 11:08:43 AM

Post# of 2719
$OPGN Commercial launch of unique AREScloud app. Uses superior whole genome sequencing (WGS).

Snippets Oct 21 PR. Ares Genetics is wholly owned OPGN subsidiary.

"Leading global health organizations have acknowledged the importance of whole genome sequencing (WGS) of bacterial isolates for effective surveillance and infection prevention and control."

"AREScloud is designed to help clinical microbiologists, epidemiologists and IPC experts overcome this challenge. The software fully automates data processing - from raw sequence data to report - and offers insights into epidemiologically and etiologically relevant information including pathogen identity, genotype, virulence, plasmids, and AMR (anti-microbial resistance)."

"In addition to generating individual sample reports, the AREScloud version that has now been commercially released for the first time introduces unique features for comparative and outbreak analysis."

Ares Genetics is actively engaged in discussions with clinical expert users and is collaborating with two major U.S. hospitals.

https://ih.advfn.com/stock-market/NASDAQ/opgen-OPGN/stock-news/86338872/opgen-subsidiary-ares-genetics-launches-arescloud

https://www.ares-genetics.cloud/auth/login?redirect=%2Fhome

https://www.ares-genetics.com/diagnostics
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OPGN News